Neuromuscular Disorders: Treatment and Management

Treatment and Management of Hereditary Metabolic Myopathies

Hereditary metabolic myopathies are a group of muscle disorders that result from a shortage of energy production (i.e., deficiency of adenosine triphosphate [ATP]). In muscle, ATP is produced by aerobic glycogenesis or glycogenolysis and glycolysis, using the respiratory chain, or…

Treatment and Management of Autoimmune Myopathies

The autoimmune inflammatory myopathies comprise five major and distinct subsets: polymyositis (PM), dermatomyositis (DM), necrotizing autoimmune myositis (NAM), overlap myositis and antisynthetase syndromes (OM-AS), and inclusion body myositis (IBM) ( ). Although moderate to severe muscle weakness, endomysial inflammation, and…

Treatment and Management of Muscular Dystrophies

Muscular dystrophies have long been recognized as heterogeneous inherited disorders, characterized by progressive skeletal muscle degeneration, weakness, and dystrophic changes in muscle biopsy. These diseases are known to have autosomal dominant, recessive, or X-linked inheritance. Clinical observations initially led to…

Treatment and Management of Disorders of the Neuromuscular Junction

Disorders of the neuromuscular junction include myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), botulism, congenital myasthenic syndrome (CMS), snakebite myasthenia, organophosphate poisoning (OPP), and hypermagnesium-induced paralysis. 1 1 Tick paralysis is excluded from this chapter because it is due to…

Treatment and Management of Segmental Neuromuscular Disorders

This chapter is devoted to focal disorders of the peripheral nervous system, including radiculopathies, plexopathies, and mononeuropathies. These conditions span a broad range of disorders, from radiculopathy due to Lyme disease and obturator neuropathy at the extremes of rarity to…

Treatment and Management of Autoimmune Neuropathies

Introduction Autoimmune peripheral neuropathies (APNs) develop when immunologic tolerance to key antigenic sites on myelin, axon, nodes of Ranvier, or ganglionic neurons is lost ( , ). These conditions may manifest either acutely or in a more chronic manner; symptoms…

Treatment and Management of Hereditary Neuropathies

The authors thank Gerald Raymond for helpful feedback on this chapter. Overview of Inherited Neuropathies Hereditary neuropathy remains a major cause of neuropathy in patients referred to tertiary centers, estimated to represent 25% to 40% of all causes of neuropathy.…